Fei Yunyun, Peng Yu, Zhang Panpan, Zhang Xia, Peng Linyi, Zhou Jiaxin, Zhang Li, Zhang Shangzhu, Liu Jinjing, Wu Di, Lai Yamin, Liu Xiaowei, Xue Huadan, Zhang Xuan, Zeng Xiaofeng, Zhang Fengchun, Zhao Yan, Zhang Wen
Objectives: This randomized, controlled clinical trial aims to compare the efficacy and safety of glucocorticoid combined with MMF and glucocorticoid monotherapy for patients with IgG4-related disease. Methods: Sixty-nine patients newly diagnosed with IgG4-related disease were randomly divided into two groups (35 patients in Group I and 34 patients in Group II). Patients in Group I received glucocorticoid monotherapy (0.6-0.8 mg/(kg·day) and tapered gradually); patients in Group II received glucocorticoid combined with MMF therapy (1-1...
January 1, 2019: Rheumatology